Evidence map›Paper›PMID 40116791›Full record

ArticlePsychology and psychotherapy2025

Modelling the longitudinal associations between schizotypy and aberrant salience: The role of mentalization and attachment.

Ercan Ozdemir, Angus MacBeth, Helen Griffiths

Abstract read
In one paragraph

Article in Psychology and psychotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ercan OzdemirSection of Clinical Psychology, School of Health in Social Science, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-5276-8367
Angus MacBethSection of Clinical Psychology, School of Health in Social Science, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-0618-044X
Helen GriffithsSection of Clinical Psychology, School of Health in Social Science, University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-8680-1682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study investigates the role of mentalization and attachment in the development of schizotypy into aberrant salience. Specifically, we examine how disruptions in these socio-cognitive capacities interact with multidimensional schizotypy to influence self-fragmentation, emotional instability and social detachment.

methodStudy variables were measured using self-report scales. A two-wave cohort study design was implemented with a 9-month assessment interval. The cross-sectional and longitudinal associations between mentalizing, attachment, negative affect, aberrant salience and schizotypy were estimated using network modelling.

resultsThe study involved 312 participants aged 18-37 years, with 77% identifying as female and 57% receiving mental health treatment during the follow-up period. Results indicated that mentalizing capacity was central in linking concurrent negative affect, attachment and psychosis risk and served as a temporal bridge connecting multiple dimensions of psychosis risk.

conclusionMentalizing difficulties can heighten psychosis risk by maintaining affective dysregulation and consolidating schizotypy. The results may be influenced by potential sampling errors, as indicated by the analyses of network stability and accuracy. Interventions promoting mentalizing capacity may attenuate psychosis risk.

Indexed as

MentalizationObject AttachmentSchizotypal Personality DisorderAdolescentAdultCross-Sectional StudiesFemaleHumansLongitudinal StudiesMalePsychotic DisordersYoung Adultaffective symptomsattachment theorymentalizationpsychosis riskschizotypy

Identifiers

PMID40116791
PMCPMC12346266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.